Talphera (TLPH) Other Working Capital Changes (2018 - 2023)
Talphera's (TLPH) quarterly Other Working Capital Changes came in at $117000.0 in Q4 2023, up 62.5% year-on-year from $72000.0 in Q4 2022, and up 200.0% quarter-over-quarter from -$117000.0 in Q3 2023.
Talphera (TLPH) Other Working Capital Changes (2018 - 2023) Analysis & Trends
Talphera's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $117000.0 for Q4 2023.
- On a quarterly basis, Other Working Capital Changes rose 62.5% year-over-year to $117000.0 in Q4 2023; TTM through Sep 2024 was $117000.0, a 258.11% increase from a year earlier, with the FY2023 full-year figure at -$29000.0, up 89.82% from the prior year.
- Other Working Capital Changes advanced to $117000.0 in Q4 2023 per TLPH's latest filing, from -$117000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q4 2023 and bottomed at -$1.6 million in Q1 2023.
- The 5-year median for Other Working Capital Changes is -$272000.0 (2025), against an average of -$132235.3.
- Biggest YoY gain for Other Working Capital Changes was 2660.92% in 2020; the steepest drop was 1369.79% in 2020.
- Year by year, Other Working Capital Changes stood at $17000.0 in 2019, then tumbled by 1352.94% to -$213000.0 in 2020, then jumped by 920.19% to $1.7 million in 2021, then tumbled by 95.88% to $72000.0 in 2022, then surged by 62.5% to $117000.0 in 2023.
- Per Business Quant, the three latest TLPH Other Working Capital Changes figures stand at $117000.0 (Q4 2023), -$117000.0 (Q3 2023), and -$59000.0 (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 117,000.00 |
| Dec 31, 2023 | 117,000.00 |
| Dec 31, 2023 | 117,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -59,000.00 |
| Jun 30, 2023 | -59,000.00 |
| Jun 30, 2023 | -59,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Dec 31, 2022 | 72,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | -346,000.00 |
| Jun 30, 2022 | -346,000.00 |